Overview
Pallister-Hall syndrome (PHS) is a rare genetic disorder characterized by hypothalamic hamartoma, central nervous system malformations, polydactyly, craniofacial anomalies, imperforate anus, and often hypopituitarism 17.Diagnosis
Key Diagnostic Criteria: Hypothalamic hamartoma, central polydactyly (often postaxial), craniofacial malformations, imperforate anus, hypopituitarism 17.
Recommended Tests: Brain MRI to identify hypothalamic hamartoma; endocrine evaluation including growth hormone, thyroid-stimulating hormone, and cortisol levels 15.
Genetic Testing: Consider GLI3 gene mutation analysis due to autosomal dominant inheritance 26.Management
First-Line Treatments: Hormonal replacement therapy tailored to specific pituitary deficiencies (e.g., growth hormone, thyroxine, hydrocortisone) 5.
Surgical Interventions: Resection of hypothalamic tumors if symptomatic or causing complications 8.
Anorectal Malformation: Surgical correction for imperforate anus 1.
Airway Management: Address cricoid stenosis with tracheostomy or endoscopic interventions if respiratory distress occurs 1.Special Populations
Pregnancy: No specific guidelines provided; monitor for potential genetic transmission 34.
Pediatrics: Early intervention for endocrine deficiencies and surgical correction of anatomical anomalies is crucial 15.
Comorbidities: Manage hypopituitarism comprehensively, addressing growth, metabolism, and stress response 5.Key Recommendations
Perform brain MRI and comprehensive endocrine evaluation in all suspected cases to confirm diagnosis and guide management (Evidence: Moderate 15).
Initiate tailored hormonal replacement therapy based on specific pituitary hormone deficiencies identified (Evidence: Moderate 5).
Consider surgical intervention for symptomatic hypothalamic tumors or severe anatomical anomalies like imperforate anus and cricoid stenosis (Evidence: Weak 18).
Monitor for variable expressivity and potential familial recurrence, suggesting genetic counseling for affected families (Evidence: Expert opinion 34).References
1 Stoll C, De Saint Martin A, Donato L, Alembik K, Sauvage P, Messer J. Pallister-Hall syndrome with stenosis of the cricoid cartilage and microphallus without hypopituitarism. Genetic counseling (Geneva, Switzerland) 2001. link
2 Kang S, Graham JM, Olney AH, Biesecker LG. GLI3 frameshift mutations cause autosomal dominant Pallister-Hall syndrome. Nature genetics 1997. link
3 Penman Splitt M, Wright C, Perry R, Burn J. Autosomal dominant transmission of Pallister-Hall syndrome. Clinical dysmorphology 1994. link
4 Thomas HM, Todd PJ, Heaf D, Fryer AE. Recurrence of Pallister-Hall syndrome in two sibs. Journal of medical genetics 1994. link
5 Sills IN, Rapaport R, Robinson LP, Lieber C, Shih LY, Horlick MN et al.. Familial Pallister-Hall syndrome: case report and hormonal evaluation. American journal of medical genetics 1993. link
6 Kuller JA, Cox VA, Schonberg SA, Golabi M. Pallister-Hall syndrome associated with an unbalanced chromosome translocation. American journal of medical genetics 1992. link
7 Finnigan DP, Clarren SK, Haas JE. Extending the Pallister-Hall syndrome to include other central nervous system malformations. American journal of medical genetics 1991. link
8 Graham JM, Saunders R, Fratkin J, Spiegel P, Harris M, Klein RZ. A cluster of Pallister-Hall syndrome cases, (congenital hypothalamic hamartoblastoma syndrome). American journal of medical genetics. Supplement 1986. link